Ontario Bioscience Innovation Organization Overview
- Investor Type
- Venture Capital
- Status
- Active
- Professionals
- 9

- Investments
- 31
- Portfolio
- 25
- Exits
- 6

Ontario Bioscience Innovation Organization General Information
Description
Ontario Bioscience Innovation Organization is a not-for-profit, membership-based organization engaged in the development of companies operating in the healthcare and life science sectors. The firm provides advocacy, promotion and strategic leadership and via collaborative partnerships with industry, academia, patients and government. The firm is based in Toronto, Canada.
Contact Information
Website
Year Founded
2009
Investor Status
Actively Seeking New Investments
Primary Investor Type
Not-For-Profit Venture Capital
Other Investor Types
Accelerator/Incubator
Primary Office
- 100 College Street
- Suite 213
- Toronto, Ontario M5G 1L7
- Canada
+1 (416) 000-0000
Ontario Bioscience Innovation Organization Investments (31)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
---|---|---|---|---|---|---|
Vasomune Therapeutics | 18-Aug-2020 | Grant | 00.000 | Biotechnology | Generating Revenue | |
0000000 0000000000 | 18-Jan-2018 | 00000 (00000 | 00000 | Surgical Devices | Out of Business | |
00000000 | 08-May-2017 | 000000000000 | Therapeutic Devices | Generating Revenue | 0000 0000000 | |
0000000000000 | 04-Apr-2017 | 000000000000 | Biotechnology | Pre-Clinical Trials | ||
0000000 | 20-Apr-2016 | 00000 | 000.00 | Monitoring Equipment | Out of Business | |
0000000 | 01-Apr-2016 | 00000 | 000.00 | Decision/Risk Analysis | Generating Revenue | |
000000000 0000000 | 01-Apr-2016 | 00000 | 000.00 | Monitoring Equipment | Generating Revenue | |
00 0000000 | 01-Apr-2016 | 00000 | 000.00 | Diagnostic Equipment | Generating Revenue | |
Ketogen Pharma | 01-Apr-2016 | Grant | 000.00 | Biotechnology | Startup | |
Oxalys Pharmaceuticals | 01-Apr-2016 | Grant | 000.00 | Drug Discovery | Startup |
Ontario Bioscience Innovation Organization Exits (6)
Company Name | Exit Date | Exit Type | Exit Size |
---|---|---|---|
Avertus | 01-Feb-2019 | Out of Business | |
000000 000000000 | 01-Aug-2018 | 000 00 00000000 | |
0000000 0000000000 | 01-Apr-2018 | 000 00 00000000 | |
0000000 0000000000 | 01-Mar-2018 | 000 00 00000000 | |
NHTherapeutics | 01-Jan-2018 | Out of Business | |
RemoteRep | 01-Oct-2016 | Out of Business |
Ontario Bioscience Innovation Organization Investments by Industry, Year, and Region
Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.
Request a free trialOntario Bioscience Innovation Organization Team (15)
Name | Title | Deals | Funds | Boards | Office |
---|---|---|---|---|---|
Gail Garland | Chief Executive Officer & President | 0 | Toronto, Canada | ||
Helen Findlay | Director | Toronto, Canada | |||
Sean Peel Ph.D | Business Development Manager, H2BB™ | Toronto, Canada | |||
Angela Drennan | Manager, Communications | Toronto, Canada | |||
Ryan Ball | Program Associate Manager, H2BB™ | Toronto, Canada |